The immunosuppressant FK506 promotes development of the chondrogenic phenotype in human synovial stromal cells via modulation of the Smad signaling pathway. [electronic resource]
Producer: 20070927Description: 709-18 p. digitalISSN:- 1063-4584
- Adult
- Cartilage, Articular -- drug effects
- Chondrocytes -- drug effects
- Chondrogenesis -- drug effects
- Female
- Gene Expression Regulation -- drug effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Phenotype
- Signal Transduction -- drug effects
- Smad Proteins -- drug effects
- Stromal Cells -- drug effects
- Tacrolimus -- therapeutic use
- Transforming Growth Factor beta1 -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.